悦心健康(002162) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥187,927,447.05, representing a 28.92% increase compared to ¥145,774,417.64 in the same period last year[8] - The net profit attributable to shareholders was -¥7,519,849.53, an improvement of 37.59% from -¥12,049,923.61 year-over-year[8] - The basic earnings per share were -¥0.0088, a 37.59% improvement from -¥0.0141 in the same period last year[8] - The company's operating revenue for Q1 2019 was ¥187,927,447.05, representing a year-on-year increase of ¥42,153,029.41 or 28.92%[19] - The net profit attributable to shareholders for Q1 2019 was -¥7,519,849.53, an improvement of ¥4,530,074.08 or 37.59% compared to the same period last year[19] - The company reported a significant increase in other income, which rose to ¥2,239,855.31, a year-on-year increase of 909.44%[19] - The company reported a net loss of ¥186,832,263.76, worsening from a loss of ¥179,312,414.23[36] - Net loss for Q1 2019 was CNY 8,147,129.65, compared to a net loss of CNY 13,047,980.45 in the previous period, indicating an improvement[44] Cash Flow - The net cash flow from operating activities improved by 52.15%, reaching -¥10,183,642.94 compared to -¥21,282,637.90 in the previous year[8] - Operating cash flow for the period was negative at -10,183,642.94, an improvement from -21,282,637.90 in the previous year[52] - The company reported cash inflows from operating activities of 206,810,584.88, compared to 175,461,911.90 in the previous year, reflecting a growth of approximately 17.9%[52] - The net cash flow from operating activities for Q1 2019 was CNY 53,961,626.66, an increase of 115.5% compared to CNY 25,051,919.38 in Q1 2018[56] - Investment activities resulted in a net cash outflow of -40,077,113.63, worsening from -17,638,563.61 in the previous year[53] - Financing activities generated a net cash outflow of -6,180,546.27, compared to a net inflow of 10,091,196.81 in the previous year, indicating a shift in financing strategy[53] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,277,295,490.22, a slight increase of 0.05% from ¥2,276,109,018.65 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 0.81% to ¥925,684,211.81 from ¥933,236,725.42 at the end of the previous year[8] - Total current assets increased to ¥733,846,143.36 from ¥723,072,045.92, representing a growth of 2.4%[34] - Total non-current assets decreased to ¥1,543,449,346.86 from ¥1,553,036,972.73, a decline of 0.6%[34] - Total liabilities increased to ¥1,335,128,967.50 from ¥1,325,740,926.15, an increase of 0.3%[35] - Total liabilities amounted to CNY 1,035,874,047.84 from CNY 998,667,308.33 in the previous period[41] - Total equity decreased to ¥942,166,522.72 from ¥950,368,092.50, a decline of 0.9%[36] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 55,382[12] - The largest shareholder, CIMIC Industrial Inc., held 46.83% of the shares, amounting to 399,795,802 shares[12] Operational Metrics - The company experienced a 263.07% increase in investment income, reaching ¥2,244,156.20 in Q1 2019[19] - The company's accounts receivable decreased by 67.45%, from ¥10,598,477.21 to ¥3,449,511.57[18] - The prepayments increased by 92.30%, from ¥11,914,934.27 to ¥22,912,858.57, primarily due to increased procurement payments[18] - The company’s management expenses rose by 45.55%, totaling ¥19,610,194.78, attributed to the acquisition of a subsidiary and increased operational costs[20] - The fair value change income for the period was reported at ¥362,785.62, reflecting gains from unredeemed financial products[20] Government Support - The company received government subsidies totaling ¥2,239,855.31, primarily from the Minhang District government in Shanghai[9] Other Financial Metrics - Research and development expenses for Q1 2019 were CNY 1,666,826.12, down from CNY 2,061,746.99 in the previous period[42] - The total amount of prepayments increased to CNY 152,010,502.83 from CNY 114,228,807.26 in the previous period[40] - The company has a total of CNY 121,609,299.52 in other comprehensive income[64] - The total amount of deferred tax assets is CNY 3,966,317.16[64]